Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

What Is The Predicted Market Size Of The Losartan Industry By 2029?

The steady expansion of the losartan market in the past few years has been observed. The projections show it escalating from $1.44 billion in 2024 to $1.49 billion in 2025 with a compound annual growth rate (CAGR) of 3.6%. The previous growth can be credited to the rising elderly population, escalating healthcare costs, an increase in incidences of diabetic nephropathy, heightened consciousness about blood pressure control, and greater use of generic ARBs.

In the coming years, the losartan market size is anticipated to experience consistent growth, scaling up to $1.76 billion by 2029 with a compound annual growth rate (CAGR) of 4.2%. This growth during the forecast period can be credited to the escalating demand for affordable antihypertensive medications, an amplified concentration on proactive healthcare, a growing incidence of lifestyle-induced diseases, broadening healthcare resources in developing markets, and the incessant introduction of generic versions. Key trends projected for the forecast period incorporate progression in drug delivery systems, the evolution of fixed-dose combo therapies, inventive strides in formulation techniques, enhanced manufacturing protocols, and the emergence of personalized medicine methods.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24284&type=smp

Which Growth Drivers Are Shaping The Losartan Market Outlook?

The escalating instances of hypertension are anticipated to fuel the progress of the losartan market. Hypertension, a state characterized by perpetually high blood pressure, can potentially increase the risk of heart disease, stroke, and other significant health problems. The rise in hypertension cases is associated with salt-laden and processed food diets, resulting in fluid accumulation and heightened heart stress. By obstructing angiotensin II – a hormone that constricts blood vessels – losartan aids in managing hypertension. This aids in easing and broadening the vessels, reducing blood pressure and alleviating the load on the heart. For example, according to data from the American Heart Association, a nonprofit organization based in the US, there were 131,454 primary deaths related to high blood pressure in January 2024, a surge from 124,508 deaths in 2021. Consequently, the escalating prevalence of hypertension is stimulating the growth of the losartan market.

How Is The Global Losartan Market Broken Down By Segment?

The losartanmarket covered in this report is segmented –

1) By Dosage: Tablet; Powder; Suspension

2) By Source: Contract Manufacturing Organizations; In-House

3) By Distribution Channel: Online; Offline

4) By Application: Hypertension; Stroke; Diabetic Nephropathy; Other Applications

5) By End-User: Adult; Pediatric

Subsegments:

1) By Tablet: 25 Milligrams (mg); 50 Milligrams (mg); 100 Milligrams (mg)

2) By Powder: 25 Milligrams (mg); 50 Milligrams (mg); 100 Milligrams (mg)

3) By Suspension: 5 Milligrams (mg) Per 5 Milliliters (mL); 10 Milligrams (mg) Per 5 Milliliters (mL); 25 Milligrams (mg) Per 5 Milliliters (mL)

Which Market Trends Are Expected To Define The Future Of The Losartan Market?

Key players within the losartan market are focusing on devising innovative products and obtaining approvals, like losartan potassium oral suspension, to promote patient adherence and broaden medicinal uses. Losartan potassium oral suspension, a liquid form of the losartan potassium medication, is aimed at those who have difficulty in swallowing pills. For instance, in March 2025, US-based biotech firm Scienture Holdings Inc., acquired approval from the FDA for Arbli, a pre-mixed liquid formulation designed for hypertension, risk reduction of stroke in hypertensive patients with left ventricular hypertrophy, and diabetic nephropathy in type 2 diabetes patients. It presents accurate dosing without compounding and is offered in a 165 mL peppermint-flavored suspension (10 mg/mL) with an 18-month shelf life at room temperature.

Who Are The Primary Market Leaders In The Losartan Market?

Major companies operating in the losartan market are Viatris Inc., Teva Pharmaceutical Industries Ltd, Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Vasudha Pharma Chem Ltd., Unichem Laboratories Ltd., Global Pharma Tek, Manus Aktteva Biopharma LLP, Emcure Pharmaceuticals Ltd., Wellona Pharma, JPM Pharma & Chemicals Pvt. Ltd.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/losartan-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Losartan Market?

North America was the largest region in the losartan market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the losartan market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=24284&type=smp

Browse Through More Reports Similar to the Global Losartan Market 2025, By The Business Research Company

Pulmonary Arterial Hypertension Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pulmonary-arterial-hypertension-global-market-report

Ocular Hypertension Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/ocular-hypertension-treatment-global-market-report

Medication Management System Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/medication-management-system-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model